🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Nutritional Maturity in Preterm Newborns (Premature Infant Oral Motor Intervention, PIOMI)

RecruitingNAAges 28 Weeks - 32 WeeksAllAtaturk University
NCT07894380 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Premature Infant Oral Motor Intervention (PIOMI) has been found to improve short-term clinical outcomes in preterm infants and contribute to their feeding skills. In preterm infants, PIOMI can improve weight and facilitate early oral feeding. Furthermore, PIOMI can shorten the length of hospital stay and the separation time between the infant and caregiver in preterm infants. The primary aim of this project is to evaluate the effect of PIOMI in mother-infant interaction (applied with the infant in the mother's arms and accompanied by the mother's voice) on feeding readiness, suckling success, mothers' breastfeeding attitudes and infants' feeding maturity in preterm newborns. The secondary objective is to investigate whether PIOMI applied in mother-infant interaction affects mothers' positive and negative emotional states.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * \- Infants who are breastfed, * have no congenital anomalies or neurological problems, * have not undergone surgery, * are in stable general condition and are fed enterally, * have no respiratory, cardiovascular or gastrointestinal problems that would prevent or complicate oral feeding, * and whose parents are willing to participate in the study. Exclusion Criteria: * Infants requiring resuscitation, * with deteriorating general condition, * with additional diagnoses such as sepsis, NEC, etc., * with excessive skin sensitivity, and * whose parents wish to be separated from work.
💊

What it tests

  • The PIOMI initiative in maternal interaction
  • Control
📍

Where

1 site
Ataturk University Faculty of Nursing
Erzurum, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy